(Total Views: 565)
Posted On: 09/17/2020 10:25:47 AM
Post# of 94

$ATOS News Article - Atossa Therapeutics Receives Second Positive Interim Safety Assessment in Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVID https://marketwirenews.com/news-releases/atos...76174.html


My Twitter: WhyteStocks